在四个欧洲国家的可能耐火性慢性咳的患病率和负担
Javier Domínguez-Ortega1, J Christian Virchow2, Laurent Guilleminault3
1Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IDIPAZ), Madrid, Spain.
ERJ open research
|July 15, 2025
概括
患有慢性咳的成人中,多达27.9%的人可能患有耐火性慢性咳 (RCC). 这种情况与与不耐药慢性咳相比,更大的健康负担和医疗保健利用率增加有关.
科学领域:
- 肺部病理学 肺部病理学
- 流行病学 流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 慢性咳 (CC) 影响了相当一部分人口.
- 耐火性或无法解释的慢性咳 (RCC) 是一个具有挑战性的临床实体.
- 了解可能的RCC的患病率和负担对于患者护理至关重要.
研究的目的:
- 估计欧洲人口中可能存在的难治性或不明原因的慢性咳 (RCC) 的患病率.
- 评估与可能的RCC相关的健康相关负担.
- 确定区分可能的RCC与非RCC的特征.
主要方法:
- 来自法国,德国,意大利和西班牙的调查数据的二次分析.
- 纳入标准:当前慢性咳 (≥8周),不吸烟,没有肺癌史,间歇性肺病,或使用ACE抑制剂/口服类固醇.
- 根据咳严重程度评分 (≥4/10) 和≥1药物类别缺乏显著缓解来定义可能的RCC;基于≥2或3药物类别的子组.
主要成果:
- 在591名 (27.9%) 的CC受访者中,有165人符合可能的RCC标准.
- 可能的RCC组显示女性比例较高 (66.7%对57.3%),生活质量得分明显较低 (EuroQoL指数:0.72对0.80;莱斯特咳问卷:13.49对15.95).
- 可能的RCC组也有更多的医疗保健访问 (9.87对过去6个月的6.26).
结论:
- 大约有27.9%的慢性咳受研究的欧洲人口可能有耐火性慢性咳.
- 可能患有RCC的患者体验到与健康相关的负担大幅增加.
- 调查结果突出了对RCC更好的识别和管理策略的需要.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
COPD: Pathogenesis and Clinical Features
531
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
531
Gastroesophageal Reflux Disease II: Clinical Features and Management
218
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
218


